Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.4%

2 terminated out of 37 trials

Success Rate

92.0%

+5.5% vs benchmark

Late-Stage Pipeline

8%

3 trials in Phase 3/4

Results Transparency

9%

2 of 23 completed with results

Key Signals

2 with results92% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
P 3 (2)
P 4 (1)

Trial Status

Completed23
Unknown11
Terminated2
Recruiting1

Trial Success Rate

92.0%

Benchmark: 86.5%

Based on 23 completed trials

Clinical Trials (37)

Showing 20 of 20 trials
NCT05591924Recruiting

Early Severe Illness TrAnslational BioLogy InformaticS in Humans

NCT00736723CompletedPrimary

NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock

NCT02922998Completed

CD64 and Antibiotics in Human Sepsis

NCT03754257Not ApplicableCompleted

Effects of Electrical Stimulation for Preventing Loss of Muscle Mass in Patients With SIRS, Sepsis and Septic Shock

NCT05703802Completed

Establishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.

NCT03784521Not ApplicableCompletedPrimary

Efficacy of Intravenous In-line Filter in Patient Undergoing Cardiac Surgery

NCT04724044Phase 3Completed

Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia

NCT05142813Unknown

A Blood Test to Diagnose Sepsis in Symptomatic Adults and Children

NCT05023954Unknown

mSEP: Testing of Physiological and Immune-metabolic Blood Markers for Maternal Sepsis

NCT03876535Completed

Performance Evaluation of the Nanomix eLab® CRP, PCT, and LAC Assays With the Nanomix eLab System

NCT04117568Terminated

The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients

NCT04901338CompletedPrimary

Cytokine Hemoadsorption in ECMO Patients

NCT04254744CompletedPrimary

SIRS in Cyanotic and Acyanotic Children in Cardiac Surgery

NCT03126032Completed

Early Detection of Glycocalyx Damage in Emergency Room Patients

NCT04289506Unknown

Validation of Molecular and Protein Biomarkers in Sepsis

NCT03884595Unknown

Early Identification of Sepsis in Children

NCT03661450CompletedPrimary

Evaluation of CDSS in Detection of SIRS and Sepsis in Pediatric Patients

NCT02052895CompletedPrimary

Utility of Presepsin in Distinguishing Between Sepsis and SIRS

NCT02704871Terminated

The Ward Study for SeptiCyte® Lab to Distinguish Between Infection-positive and Infection-negative SIRS

NCT01686776Phase 3Completed

A Prospective Validation Study of Albumin Kinetics With Tracer 123 I-HSA

Scroll to load more

Research Network

Activity Timeline